Lodico A - Search Results

1

Theranostic application of miR-429 in HER2+ breast cancer.

Cava C, Novello C, Martelli C, Lodico A, Ottobrini L, Piccotti F, Truffi M, Corsi F, Bertoli G, Castiglioni I. Cava C, et al. Among authors: lodico a. Theranostics. 2020 Jan 1;10(1):50-61. doi: 10.7150/thno.36274. eCollection 2020. Theranostics. 2020. PMID: 31903105 Free PMC article.

2

Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.

Lo Dico A, Valtorta S, Martelli C, Belloli S, Gianelli U, Tosi D, Bosari S, Degrassi A, Russo M, Raccagni I, Lucignani G, Moresco RM, Ottobrini L. Lo Dico A, et al. Mol Imaging Biol. 2014 Apr;16(2):210-23. doi: 10.1007/s11307-013-0669-0. Mol Imaging Biol. 2014. PMID: 24002614

3

Cellular magnetic resonance with iron oxide nanoparticles: long-term persistence of SPIO signal in the CNS after transplanted cell death.

Cianciaruso C, Pagani A, Martelli C, Bacigaluppi M, Squadrito ML, Lo Dico A, De Palma M, Furlan R, Lucignani G, Falini A, Biffi A, Ottobrini L, Politi LS. Cianciaruso C, et al. Nanomedicine (Lond). 2014 Jul;9(10):1457-74. doi: 10.2217/nnm.14.84. Epub 2014 May 13. Nanomedicine (Lond). 2014. PMID: 24823433

4

Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model.

Lo Dico A, Martelli C, Valtorta S, Raccagni I, Diceglie C, Belloli S, Gianelli U, Vaira V, Politi LS, Bosari S, Lucignani G, Moresco RM, Ottobrini L. Lo Dico A, et al. Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1093-105. doi: 10.1007/s00259-015-3040-7. Epub 2015 Mar 27. Eur J Nucl Med Mol Imaging. 2015. PMID: 25813354

5

Optical imaging probes in oncology.

Martelli C, Lo Dico A, Diceglie C, Lucignani G, Ottobrini L. Martelli C, et al. Oncotarget. 2016 Jul 26;7(30):48753-48787. doi: 10.18632/oncotarget.9066. Oncotarget. 2016. PMID: 27145373 Free PMC article. Review.

6

MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma.

Lo Dico A, Costa V, Martelli C, Diceglie C, Rajata F, Rizzo A, Mancone C, Tripodi M, Ottobrini L, Alessandro R, Conigliaro A. Lo Dico A, et al. Theranostics. 2016 May 8;6(8):1105-18. doi: 10.7150/thno.14700. eCollection 2016. Theranostics. 2016. PMID: 27279905 Free PMC article.

7

MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells.

Costa V, Lo Dico A, Rizzo A, Rajata F, Tripodi M, Alessandro R, Conigliaro A. Costa V, et al. Oncotarget. 2017 Apr 11;8(15):24292-24302. doi: 10.18632/oncotarget.14464. Oncotarget. 2017. PMID: 28061476 Free PMC article.

8

Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models.

Valtorta S, Lo Dico A, Raccagni I, Gaglio D, Belloli S, Politi LS, Martelli C, Diceglie C, Bonanomi M, Ercoli G, Vaira V, Ottobrini L, Moresco RM. Valtorta S, et al. Oncotarget. 2017 Dec 6;8(68):113090-113104. doi: 10.18632/oncotarget.23028. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348889 Free PMC article.

9

Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide.

Lo Dico A, Martelli C, Diceglie C, Lucignani G, Ottobrini L. Lo Dico A, et al. Front Oncol. 2018 Jul 2;8:249. doi: 10.3389/fonc.2018.00249. eCollection 2018. Front Oncol. 2018. PMID: 30013951 Free PMC article.

10

Role of Metformin and AKT Axis Modulation in the Reversion of Hypoxia Induced TMZ-Resistance in Glioma Cells.

Lo Dico A, Valtorta S, Ottobrini L, Moresco RM. Lo Dico A, et al. Front Oncol. 2019 May 31;9:463. doi: 10.3389/fonc.2019.00463. eCollection 2019. Front Oncol. 2019. PMID: 31214505 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters